Department of Respiratory Medicine, Tokyo Shinagawa Hospital, Japan.
Department of Surgery, Tokyo Shinagawa Hospital, Japan.
Intern Med. 2021;60(1):123-130. doi: 10.2169/internalmedicine.5475-20. Epub 2021 Jan 1.
Case 1: A 65-year-old man with novel coronavirus infection (COVID-19) complicated with acute respiratory failure. On admission, the patient was started on favipiravir and corticosteroid. However, due to a lack of significant improvement, he was introduced to mechanical ventilation and extracorporeal membrane oxygenation (ECMO). Although iliopsoas hematoma occurred as a complication, the patient recovered. Case 2: A 49-year-old man with COVID-19 had been started on favipiravir and corticosteroid. Due to progressive respiratory failure, the patient underwent mechanical ventilation and ECMO. The patient recovered without complications. We successfully treated these severe cases with a multimodal combination of pharmacological and non-pharmacological supportive therapy.
病例 1：一名 65 岁男性，患有新型冠状病毒感染（COVID-19）合并急性呼吸衰竭。入院时，给予患者法匹拉韦和皮质类固醇治疗。然而，由于改善不明显，患者被引入机械通气和体外膜肺氧合（ECMO）治疗。尽管发生了髂腰肌血肿这一并发症，但患者得以康复。病例 2：一名 49 岁男性患有 COVID-19，已开始接受法匹拉韦和皮质类固醇治疗。由于进行性呼吸衰竭，患者接受了机械通气和 ECMO。患者在没有并发症的情况下康复。我们成功地使用药物和非药物支持治疗的多模式联合治疗了这些重症病例。
